Table 2.
Condition | Number of control sample prevalence rate (%) | Number of preexisting prevalence (24 months prior to AD Medications) rate (%) | Number of newly developed incidence (after AD medications) rate (%) |
---|---|---|---|
Obesity, weight gain | 388 (8.6) | 791 (6.6) | 1038 (9.2) |
Type 2 diabetes mellitus | 85 (1.9) | 264 (2.1) | 363 (3.1) |
Dyslipidemia | 486 (10.8) | 829 (6.9) | 756 (6.7) |
Nausea, vomiting | 1174 (26.1) | 2561 (26.0) | 2226 (18.6) |
Anorexia, weight loss | 80 (1.8) | 398 (3.5) | 639 (5.3) |
Sexual/reproductive | 296 (6.6) | 399 (3.7) | 1169 (9.8) |